Clinical and serological features of 35 patients with anti-Ki autoantibodies

Lupus

Volumn 14, Issue 10, 2005, Pages 837-841

  Cavazzana, Ilaria ^a,b   Franceschini, F ^a   Vassalini, C ^a   Danieli, E ^a   Quinzanini, M ^a   Airo P ^a   Cattaneo, R ^a  

^a Rheumatology Unit   (Italy)

^b Servizio di Immunologia Clinica   (Italy)

Author keywords

Anti ENA; Anti Ki; Anti SL; Sj gren's syndrome; Systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CD30 ANTIGEN; DNA ANTIBODY; KI AUTOANTIBODY; RHEUMATOID FACTOR; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FREQUENCY ANALYSIS; FREQUENCY ANALYZER; HUMAN; KIDNEY DISEASE; LABORATORY TEST; MALE; PHOTOSENSITIVITY; PREVALENCE; PRIORITY JOURNAL; RASH; RAYNAUD PHENOMENON; SEROLOGY; SJOEGREN SYNDROME; SKIN; STATISTICAL SIGNIFICANCE; SYSTEMIC LUPUS ERYTHEMATOSUS; XEROPHTHALMIA; XEROSTOMIA; ZYGOMA;

ADULT; ANTIGENS, SURFACE; AUTOANTIBODIES; AUTOANTIGENS; COHORT STUDIES; COUNTERIMMUNOELECTROPHORESIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PROTEASOME ENDOPEPTIDASE COMPLEX; RETROSPECTIVE STUDIES; SJOGREN'S SYNDROME;

EID: 27744499887     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203305lu2226oa     Document Type: Article

References (44)

1. Harmon C, Peebles C, Tan EM. SL - a new precipitating system. Arthritis Rheum 1981; 24 (Suppl): S122 (abstract).
2. Bernstein RM, Morgan SH, Bunn CC, Gainey RC, Hughes GRV, Mathews MB. The SL autoantibody-antigen system: clinical and biochemical studies. Ann Rheum Dis 1986; 45: 353-358.
3. Tojo T, Kaburaki J, Hoyokawa M, Okamoto T, Tomii M, Homma M. Precipitating antibody to a soluble nuclear antigen 'Ki' with specificity for SLE. Ryumachi 1981; 21: 129-140.
4. Nikaido T, Shimada K, Shibata M et al. Cloning and nucleotide sequence of cDNA for Ki antigen, a highly conserved nuclear protein detected with sera from patients with systemic lupus erythematosus. Clin Exp Immunol 1990; 79: 209-214.
5. Takeuchi K, Kaneda K, Kawakami I, Takasaki Y, Hashimoto H. Autoantibodies recognizing proteins copurified with PCNA in patients with connective tissue diseases. Mol Biol Rep 1996; 23: 43-46.
6. Takasaki Y, Kogure T, Takeuchi K et al. Reactivity of anti-proliferating cell nuclear antigen (PCNA) murine monoclonal antibodies and human autoantibodies to the PCNA multiprotein complexes involved in cell proliferation. J Immunol 2001; 166: 4780-4787.
7. Matsudaira R, Takeuchi K, Takeuchi Y, Yano T, Matsushita M, Hashimoto H. Relationships between autoantibody responses to deletion mutants of Ki antigen and clinical manifestations of lupus. J Rheumatol 2003; 30: 1208-1214.
8. Takasaki Y, Yano T, Hirokawa K et al. An epitope on Ki antigen recognized by autoantibodies from lupus patients shows homology with the SV 40 large T antigen nuclear localization signal. Arthritis Rheum 1996; 39: 855-862.
9. Riboldi P, Asero R, Origgi L, Crespi S. The SL/Ki system in connective tissue diseases: incidence and clinical associations. Clin Exp Rheum 1987; 5: 29-33.
10. Boey ML, Peebles CL, Tsay G, Feng PH, Tan EM. Clinical and autoantibody correlations in Orientals with systemic lupus erythematosus. Ann Rheum Dis 1988; 47: 918-923.
11. Parodi A, Nigro A, Rebora A. Anti-SL/Ki antibody in a patients with a fatal connective tissue overlap disease. Br J Dermatol 1989; 121: 243-246.
12. Yamanaka K, Takasaki Y, Nishida Y, Shimada K, Shibata M, Hashimoto H. Detection and quantification of anti-Ki antibodies by enzyme-linked immunosorbent assay using recombinant Ki antigen. Arthritis Rheum 1992; 35: 667-671.
13. Sakamoto M, Takasaki Y, Yamanaka K, Kodama A, Hashimoto H, Hirose S. Purification and characterization of Ki antigen and detection of anti-Ki antibody by enzyme-linked immunosorbent assay in patients with systemic lupus erythematosus. Arthritis Rheum 1989; 32: 1554-1562.
14. Tan EM, Cohen AM, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
15. Subcommittee for Scleroderma Criteria of the American Rheumatic Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-590.
16. Vitali C, Bombardieri S, Moutsopoulos HM et al. Assessment of European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. Ann Rheum Dis 1996; 55: 116-121.
17. Mosca M, Neri R, Bombardieri S. Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria. Clin Exp Rheumatol 1999; 17: 615-620.
18. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Eng J Med 1975; 292: 344-347.
19. Alarcon-Segovia D, Cardiel MH. Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J Rheumatol 1989; 16: 328-334.
20. Wilson WA, Gharavi AE, Koike T et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999; 42: 1309-1311.
21. Bird HA, Esselinckx W, Dixon AS, Mowat AG, Wood PH. An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 1979; 38: 434-439.
22. Alvarez F, Berg PA, Bianchi FB et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-938.
23. Harris EN. The second international anti-cardiolipin standardization workshop. The Kingston anti-phospholipid antibody study (KAPS) group. Ann J Clin Pathol 1990; 94: 476-484.
24. Balestrieri G, Tincani A, Spatola L et al. Anti-β2 glycoprotein I: a marker of antiphospholipid syndrome? Lupus 1995; 4: 122-130.
25. Bernstein RM, Bunn CC, Hughes GRV. Identification of antibodies to acidic antigens by counterimmunoelectrophoresis. Ann Rheum Dis 1982; 41: 554-555.
26. Clark G, Reichlin M, Tomasi TB. Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythematosus. J Immunol 1969; 102: 117-122.
27. Venables PJW, Smith PR, Maini RN. Purification and characterization of the Sjögren's Syndrome A and B antigens. Clin Exp Immunol 1983; 54: 731-738.
28. Matsunaga K. The "anti-Ki" syndrome: major clinical features. Rinsho Byori 1993; 41: 882-887.
29. Culp KS, Fleming CR, Duffy J, Baldus WP, Dickson ER. Autoimmune associations in primary biliary cirrhosis. Mayo Clin Proc 1982; 57: 365-370.
30. Matsumoto T, Kobayashi S, Shimizu H et al. The liver in collagen diseases: pathologic study of 160 cases with particular reference to hepatic arteritis, primary biliary cirrhosis, autoimmune hepatitis and nodular regenerative hyperplasia of the liver. Liver 2000; 20: 366-373.
31. Remmel T, Piirsoo A, Koiveer A et al. Clinical significance of different antinuclear antibodies patterns in the course of primary biliary cirrhosis. Hepatogastroenterology 1996; 43: 1135-1140.
32. Worman HJ, Courvalin JC. Antinuclear antibodies specific for primary biliary cirrhosis. Autoimmun Rev 2003; 2: 211-217.
33. Clark M, Sack K. Deforming arthropathy complicating primary biliary cirrhosis. J Rheumatol 1991; 18: 619-621.
34. Mackay IR. Hepatic disease and systemic lupus erythematosus: coincidence or convergence. In Lahita RG ed. Systemic lupus erythematosus, 3rd edn. San Diego, CA: Academic Press, 1999: 747-763.
35. Mackay IR, Weiden S, Hasker J. Autoimmune hepatitis. Ann NY Acad Sci 1965; 124: 767.
36. Czaja AJ, Nishioka M, Morshed S, Hachiya T. Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis. Gastroenterology 1994; 107: 200-207.
37. Penner E, Kindas-Mugge I, Hitchman E, Sauermann G. Nuclear antigens recognised by autoantibodies present in liver disease sera. Clin Exp Immunol 1986; 63: 428-433.
38. Omagari K, Ohba K, Kadokawa Y et al. Anti-extractable nuclear antigens (ENA) antibodies in patients with chronic hepatitis C before and after treatment with interferon. Autoimmunity 2003; 36: 269-273.
39. D'Amico E, Palazzi C, Cacciatore P et al. Anti-ENA antibodies in patients with chronic hepatitis C virus infection. Dig Dis Sci 2002; 47: 755-759.
40. Ramos-Casals M, Garcia-Carrasco M, Cervera R et al. Hepatitis C virus infection mimicking primary Sjögren's syndrome. A clinical and immunologic description of 35 cases. Medicine (Baltimore) 2001; 80: 1-8.
41. Wakasugi M, Sato T, Maruyama Y, Ueno M, Arakawa M. A case of systemic erythematosus diagnosed 7 years after epileptic seizure and developed chorea during prednisolone treatment. Ryumachi 1996; 36: 545-550.
42. Francoeur AM, Peebles CL, Gompper ET, Tan EM. Identification of the Ki (Ku, p70/80) autoantigens and analysis of anti-Ki autoantibody reactivity. J Immunol 1986; 136: 1648-1653.
43. Mimori T, Suwa A, Hama N. Clinical significance of anti-Ku antibodies. Nippon Rinsho 1990; 48: 535-538.
44. Matsunaga K, Tsuji T, Satoh S, Ohta S, Tani K. The anti-Ki syndrome: clinical pictures. In Homma M, Sugai S, Tojo T, Miyasaka N, Akizuki M eds. Sjögren's syndrome - state of the art. Amsterdam: Kugler, 1994: 583-584.